Mike Arnold of Path Trading Partners provides valuable insights into the technical aspects of the market, emphasizing the importance of understanding potential pitfalls and managing positions effectively. He joins podcast hosts Jim Iurio (⁠⁠⁠⁠@jimiurio⁠⁠⁠⁠) and Bob Iaccino (⁠⁠⁠⁠@Bob_Iaccino⁠⁠⁠⁠) to break down the S&P, Nasdaq and Russell, looking at specific stocks like Nvidia and Tesla, but with a cautionary tale about blindly buying every dip. Drawing parallels to historical examples like Cisco during the dot-com era, Mike Arnold urges listeners to be mindful of the potential risks associated with overextended stocks. The trio banter about market sentiment and the eccentricities of certain trades and Jim reveals a recent trade inspired by Nancy Pelosi's investment moves. The discussion explores the implications of following prominent figures in the market and the need for prudent risk management. They also discuss the controversial world of pharmaceuticals and the impact of the drug Ozempic on both the market and consumers, Bobby brings attention to emerging headlines surrounding Ozempic, linking it to various fitness influencers, medical professionals, and even alleged copycat drugs. The hosts analyze the price action of Novo Nordisk, drawing parallels with previous market trends in companies like Tesla and Nvidia. The focus shifts to broader market indicators, such as the QQQ-IWM ratio with Mike introducing the concept of a potential market shift, emphasizing the importance of monitoring specific triggers and setting alerts for informed decision-making. The hosts wrap up the episode by touching on Proof, presumably referring to a cryptocurrency or related market segment. 

This episode is sponsored by Mint Mobile. 

$15 for your first 3 months. Visit site below:

trymintmobile.com/futuresedge  

Produced by Haynow Media